PUBLIC CONTRACT · 2023
099-10079761 -octreotido 30MG po susp. Inj. Fr im - Cpa 47/2021
- Contract value
- €836.14
- Signed on
- 20 November 2023
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 11687742PUBLISHED SUBJECT
099-10079761 -OCTREOTIDO 30MG PO SUSP. INJ. FR IM - CPA 47/2021
Parties involved
- Place of performance
- Portugal, Viana do Castelo, Viana do Castelo
- NUTS region
- PT111 - Alto Minho
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- NOVARTIS FARMA - PROD FARMACEUTICOS, SA · Tax ID 500063524
Values and timeline
- Contract price
- €836.14
- Procedure base price
- €836.14
- Total effective price
- Not reported on Portal BASE
- Publication date
- 9 September 2025
- Award date
- 20 November 2023
- Signing date
- 20 November 2023
- Performance period
- 61 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Monofator
- CPV code
- 33690000-3 - Medicamentos vários
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
- Framework agreement
- CP 2021/47 - Medicamentos do aparelho locomotor, usados no tratamento das doenças endócrinas e hormonas
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 7822597
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.